Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Study report: Primary cutaneous lymphomas

Skin-directed or systemic therapy?

    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • RX
    • Studies
  • 2 minute read

Diffuse large B-cell lymphoma is the most common malignant tumor of the lymphatic system. The primary objective of a retrospective clinical study led by Charité-Universitätsmedizin Berlin was to compare systemic and skin-directed therapies in primary cutaneous lymphoma (CBCL) with regard to survival and recurrence rates as well as time to the next line of therapy.

There are few research findings to date regarding the effectiveness of systemic and skin-directed therapies (SDT) in primary cutaneous B-cell lymphoma (CBCL), as well as the respective survival and recurrence rates. The “time to next treatment” (ZZNT) is defined as the time from the start of treatment to the start of the next line of therapy and serves as a surrogate marker for efficacy, toxicity and patient compliance when evaluating treatment options. To date, ZZNT has been evaluated in clinical trials primarily for primary cutaneous T-cell lymphomas.

Methodology

Clinical data from patients of the Central Registry for Cutaneous Lymphoma of the Charité were extracted and analyzed using descriptive statistics. A total of 98 patients with CBCL were identified: 44 with follicular center lymphoma (FCL), 43 with marginal zone lymphoma (MZL) and 11 with diffuse large B-cell lymphoma/leg type (DLBCL-LT). The average age at first diagnosis was 53, 48 and 76 years respectively. The SDT evaluated in this study included excision, radiotherapy, triamcinolone intralesional (i.l.) and topical steroids; systemic therapies included interferon-α (IFN-α), (R)-CHOP chemotherapy and rituximab.

Results

On average, patients received 2 treatments. In patients with FCL, triamcinolone (i.l.), radiotherapy and excision were associated with the longest CNT, averaging 29, 24 and 24 months, respectively (Table 1) . In MCL, excision, IFN-α and radiotherapy were associated with the longest CNT, averaging 23, 15 and 13 months, respectively. In DLBCL-LT, CHOP, excision and rituximab had the largest ZZNT with an average of 38, 32 and 18 months, respectively. Within 5 years of initial diagnosis, 36% and 35% of patients with FCL and MZL respectively relapsed. In patients with DLBCL-LT, the survival rate 5 years after initial diagnosis was 27%.

Conclusion

This retrospective study represents the first investigation of ZZNT in patients with CBCL. In this cohort, FCL and MZL patients relapsed with similar frequency. Aggressive courses of DLBCL-LT have been confirmed in the literature. Compared to systemic therapies, SDT showed superiority in FCL and MZL by an average of 4-16 months. In view of the rarity of CBCL and the nevertheless high number of cases in the present cohort, the results can support clinical treatment decisions.

Source: Cankaya R, et al.: Hautgerichtete oder systemische Therapien bei primär kutanem B-Zell-Lymphom? Eine retrospektive Analyse der Zeit bis zur nächsten Therapieline, ePoster (eP016), Deutscher Hautkrebskongress/ ADO-Jahrestagung, Hamburg, 06–09.09.2023.

DERMATOLOGIE PRAXIS 2023; 33(6): 25
InFo ONKOLOGIE & HÄMATOLOGIE 2023: 11(6): 31

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • B-cell lymphomas
  • Diffuse large B-cell lymphoma
  • Primary cutaneous lymphomas
  • skin-directed therapy
  • Systemic therapy
Previous Article
  • Translational neuroscience

Treatment research in psychiatry, neurology and psychology

  • Congress Reports
  • Neurology
  • Psychiatry and psychotherapy
  • RX
  • Studies
View Post
Next Article
  • Tofacitinib for ulcerative colitis

Study shows real-world evidence for efficacy and safety

  • Congress Reports
  • Gastroenterology and Hepatology
  • General Internal Medicine
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 4 min
  • Journal Club: Drinking restriction in heart failure

First large-scale study found no differences

    • Cardiology
    • Education
    • General Internal Medicine
    • Nutrition
    • Prevention and health care
    • RX
    • Studies
View Post
  • 3 min
  • Therapy adherence and patient selection

Injection fatigue in relapsing-remitting multiple sclerosis

    • Education
    • Neurology
    • RX
    • Studies
View Post
  • 5 min
  • Deep vein thrombosis

Outpatient or inpatient treatment?

    • Angiology
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Phlebology
    • RX
    • Studies
View Post
  • 5 min
  • Sarcoidosis, echinococcosis & Co.

Suspected symptoms and differential diagnoses

    • Cardiology
    • Cases
    • Congress Reports
    • Pneumology
    • RX
View Post
  • 12 min
  • Cancer prevention

Constant dripping – alcohol and cancer

    • CME continuing education
    • General Internal Medicine
    • Oncology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Steatotic liver disease

GLP-1RA in MASH – what’s new?

    • Congress Reports
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 6 min
  • Chronic pruritus: “Tour d'horizon”

Focus on new anti-inflammatory therapeutic approaches

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 5 min
  • Multiple sclerosis

Unexpected side effects when switching from natalizumab to a biosimilar

    • Education
    • Neurology
    • Pharmacology and toxicology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Constant dripping – alcohol and cancer
  • 2
    Hurdles to pain treatment for autistic patients
  • 3
    Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)
  • 4
    Treatment of comorbidities in older people
  • 5
    New nomenclature for non-alcoholic fatty liver disease

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.